Wave Life Sciences
WVE
90 hedge funds and large institutions have $236M invested in Wave Life Sciences in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 17 closing their positions.
17% more call options, than puts
Call options by funds: $8.84M | Put options by funds: $7.55M
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
2% more funds holding
Funds holding: 88 → 90 (+2)
7% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 30
4.05% less ownership
Funds ownership: 90.08% → 86.03% (-4.1%)
63% less capital invested
Capital invested by funds: $634M → $236M (-$398M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$41.8M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$20.8M |
| 3 |
Primecap Management
Pasadena,
California
|
+$11.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.08M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$3.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$80.3M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$20.5M |
| 3 |
DM
Deerfield Management
New York
|
-$16.6M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$3.94M |
| 5 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
-$3.13M |
WVE Hedge Fund Activity: Q4 2019 in Review
90 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q4 2019, worth a combined $236M — down 63% from $634M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new WVE positions and 17 closed out — a net gain of 2 holders — while 32 added to existing stakes and 30 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $41.8M. The largest seller was Janus Henderson Group, cutting an estimated $80.3M.
- 90 institutional investors held Wave Life Sciences (WVE) as of Q4 2019, up from 88 in Q3 2019.
- Funds reported $236M of Wave Life Sciences stock for Q4 2019, down 63% quarter-over-quarter.
- 19 funds opened new Wave Life Sciences positions in Q4 2019 and 17 closed out, a net change of +2 holders.
- The largest Wave Life Sciences buyer in Q4 2019 was RTW Investments, an estimated $41.8M added.
- The largest Wave Life Sciences seller in Q4 2019 was Janus Henderson Group, an estimated $80.3M sold.
Based on aggregated 13F filings for Q4 2019.